Role of proteases in the release of porcine epidemic diarrhea virus from infected cells

Journal of Virology

Volumn 85, Issue 15, 2011, Pages 7872-7880

  Shirato, Kazuya ^a   Matsuyama, Shutoku ^a   Ujike, Makoto ^b   Taguchi, Fumihiro ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUPEPTIN; PROTEINASE; SERINE PROTEINASE; SIALIDASE; TRANSMEMBRANE TYPE II SERINE PROTEASE 2; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIVISION; CONTROLLED STUDY; COPY NUMBER VARIATION; ELECTRON MICROSCOPY; NONHUMAN; PORCINE EPIDEMIC DIARRHEA; PORCINE EPIDEMIC DIARRHEA VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; SYNCYTIUM; VERO CELL; VIRION; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL FUSION; CERCOPITHECUS AETHIOPS; DNA PRIMERS; MICROSCOPY, ELECTRON; PEPTIDE HYDROLASES; POLYMERASE CHAIN REACTION; PORCINE EPIDEMIC DIARRHEA VIRUS; VERO CELLS; VIRUS REPLICATION;

CORONAVIRUS; ORTHOMYXOVIRIDAE; PORCINE EPIDEMIC DIARRHEA VIRUS; SUIDAE;

EID: 79960425220     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00464-11     Document Type: Article

References (49)

1. Air, G. M., and W. G. Laver. 1989. The neuraminidase of influenza virus. Proteins 6:341-356.
2. Ami, Y., et al. 2008. Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice. Microbiol. Immunol. 52:118-127.
3. Belouzard, S., V. C. Chu, and G. R. Whittaker. 2009. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl. Acad. Sci. U. S. A. 106:5871-5876.
4. Bosch, B. J., W. Bartelink, and P. J. Rottier. 2008. Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J. Virol. 82:8887-8890.
5. Bosch, B. J., R. van der Zee, C. A. de Haan, and P. J. Rottier. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77:8801-8811.
6. Böttcher, E., et al. 2006. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80:9896-9898.
7. Chandran, K., N. J. Sullivan, U. Felbor, S. P. Whelan, and J. M. Cunningham. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645.
8. de Haan, C. A., K. Stadler, G. J. Godeke, B. J. Bosch, and P. J. Rottier. 2004. Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J. Virol. 78:6048-6054.
9. Dreitlein, W. B., J. Maratos, and J. Brocavich. 2001. Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza. Clin. Ther. 23:327-355.
10. Duarte, M., and H. Laude. 1994. Sequence of the spike protein of the porcine epidemic diarrhoea virus. J. Gen. Virol. 75(Pt 5):1195-1200.
11. Fitzpatrick, K., et al. 2010. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog. 6:e1000701.
12. Glowacka, I., et al. 2011. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike-protein for membrane fusion and reduces viral control by the humoral immune response. J. Virol. 85:4122-4134.
13. Hallenberger, S., et al. 1992. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360:358-361.
14. Holmes, K. V., and S. R. Compton. 1995. Coronavirus receptors, p. 55-71. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, NY.
15. Huang, I. C., et al. 2006. SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry. Adv. Exp. Med. Biol. 581:335-338.
16. Kaletsky, R. L., J. R. Francica, C. Agrawal-Gamse, and P. Bates. 2009. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 106:2886-2891.
17. Kawaoka, Y. 2005. How Ebola virus infects cells. N. Engl. J. Med. 352:2645-2646.
18. Kawase, M., K. Shirato, S. Matsuyama, and F. Taguchi. 2009. Proteasemediated entry via the endosome of human coronavirus 229E. J. Virol. 83:712-721.
19. Kubo, H., and F. Taguchi. 1993. Expression of the S1 and S2 subunits of murine coronavirus JHMV spike protein by a vaccinia virus transient expression system. J. Gen. Virol. 74(Pt 11):2373-2383.
20. Kusanagi, K., et al. 1992. Isolation and serial propagation of porcine epidemic diarrhea virus in cell cultures and partial characterization of the isolate. J. Vet. Med. Sci. 54:313-318.
21. Lai, M. M., and D. Cavanagh. 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1-100.
22. Li, B. X., J. W. Ge, and Y. J. Li. 2007. Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus. Virology 365:166-172.
23. Liu, C., M. C. Eichelberger, R. W. Compans, and G. M. Air. 1995. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69:1099-1106.
24. Madu, I. G., S. L. Roth, S. Belouzard, and G. R. Whittaker. 2009. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J. Virol. 83:7411-7421.
25. Matsuyama, S., et al. 2010. Efficient activation of SARS coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol. 84:12658-12664.
26. Matsuyama, S., and F. Taguchi. 2009. Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. J. Virol. 83:11133-11141.
27. Matsuyama, S., M. Ujike, S. Morikawa, M. Tashiro, and F. Taguchi. 2005. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc. Natl. Acad. Sci. U. S. A. 102:12543-12547.
28. Nagai, Y., N. M. Inocencio, and B. Gotoh. 1991. Paramyxovirus tropism dependent on host proteases activating the viral fusion glycoprotein. Behring Inst. Mitt. 89:35-45.
29. Neil, S. J., S. W. Eastman, N. Jouvenet, and P. D. Bieniasz. 2006. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog. 2:e39.
30. Neil, S. J., V. Sandrin, W. I. Sundquist, and P. D. Bieniasz. 2007. An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2:193-203.
31. Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33:159-163.
32. Palese, P., K. Tobita, M. Ueda, and R. W. Compans. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397-410.
33. Paoloni-Giacobino, A., H. Chen, M. C. Peitsch, C. Rossier, and S. E. Antonarakis. 1997. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics 44:309-320.
34. Park, J. E., D. J. Cruz, and H. J. Shin. 2010. Trypsin-induced hemagglutination activity of porcine epidemic diarrhea virus. Arch. Virol. 155:595-599.
35. Pensaert, M. B., and P. de Bouck. 1978. A new coronavirus-like particle associated with diarrhea in swine. Arch. Virol. 58:243-247.
36. Qiu, Z., et al. 2006. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J. Virol. 80:5768-5776.
37. Rott, R., H. D. Klenk, Y. Nagai, and M. Tashiro. 1995. Influenza viruses, cell enzymes, and pathogenicity. Am. J. Respir. Crit. Care Med. 152:S16-S19.
38. Shirogane, Y., et al. 2008. Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J. Virol. 82:8942-8946.
39. Shulla, A., et al. 2011. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J. Virol. 85:873-882.
40. Simmons, G., et al. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U. S. A. 102:11876-11881.
41. Simmons, G., et al. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. U. S. A. 101:4240-4245.
42. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
43. Spaan, W., D. Cavanagh, and M. C. Horzinek. 1988. Coronaviruses: structure and genome expression. J. Gen. Virol. 69(Pt 12):2939-2952.
44. Steinhauer, D. A. 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20.
45. Sturman, L. S., C. S. Ricard, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:904-911.
46. Walker, J. A., et al. 1994. Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus. J. Virol. 68:1213-1218.
47. Watanabe, R., et al. 2008. Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J. Virol. 82:11985-11991.
48. Yamada, Y. K., K. Takimoto, M. Yabe, and F. Taguchi. 1997. Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the S protein. Virology 227:215-219.
49. Yoshikura, H., and S. Tejima. 1981. Role of protease in mouse hepatitis virus-induced cell fusion. Studies with a cold-sensitive mutant isolated from a persistent infection. Virology 113:503-511.